Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.85
|
9.39
|
7.24
|
6.99
|
7.395
|
7.27
|
|
|
1 436 575.74
|
1 837.00
|
2.88
|
9.13
|
7.39
|
7.00
|
7.52
|
7.20
|
|
|
2 490 285.67
|
1 635.00
|
3.00
|
9.39
|
7.63
|
7.25
|
7.97
|
7.50
|
|
|
1 497 890.03
|
2 539.00
|
7.31
|
7.86
|
7.32
|
7.18
|
7.68
|
7.53
|
|
|
1 073 637.04
|
1 262.00
|
7.19
|
7.73
|
7.38
|
7.15
|
7.56
|
7.18
|
|
|
717 075.06
|
1 212.00
|
2.96
|
9.39
|
7.68
|
7.31
|
7.79
|
7.31
|
|
|
565 109.63
|
1 247.00
|
3.01
|
9.39
|
7.49
|
7.37
|
7.70
|
7.54
|
|
|
677 917.95
|
1 481.00
|
2.96
|
9.39
|
7.38
|
7.34
|
7.48
|
7.39
|
|
|
415 253.19
|
1 118.00
|
3.02
|
9.39
|
7.71
|
7.45
|
7.715
|
7.49
|
|
|
638 079.27
|
1 563.00
|
3.08
|
9.39
|
7.97
|
7.63
|
8.07
|
7.70
|
|
|
786 939.76
|
1 782.00
|
Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.